efficacy and safety of efgartigimod to treat myasthenia gravis
Published 2 years ago • 1.7K plays • Length 5:46Download video MP4
Download video MP3
Similar videos
-
5:06
efficacy and safety of weekly subcutaneous efgartigimod for myasthenia gravis
-
5:45
advance iv results: efficacy and safety of intravenous efgartigimod in adults with primary itp
-
2:55
ash highlights: efgartigimod safe and effective in treating immune thrombocytopenia (itp)
-
7:04
efgartigimod in patients with generalized myasthenia gravis: adapt and adapt
-
3:57
mechanism of action of rozanolixizumab to treat myasthenia gravis
-
13:24
treatment options for myasthenia gravis
-
55:12
vyvgart: an educational webinar on the newly fda approved drug to treat mg
-
5:41
ash 2022: efficacy & safety of iv efgartigimod in adults with primary immune thrombocytopenia: ...
-
4:05
updates on rozanolixizumab and zilucoplan to treat myasthenia gravis
-
2:03
current myasthenia gravis treatment options are limited
-
4:26
myasthenia gravis and vision
-
4:59
adapt analysis: efgartigimod for generalized myasthenia gravis
-
7:14
phase ii study of efgartigimod in pemphigus vulgaris and foliaceus, m. goebeler et al
-
1:00:13
research webinar: learn about vyvgart™ for generalized myasthenia gravis
-
7:17
vyvgart for myasthenia gravis: a pharmacist's thoughts
-
4:04
results of phase ii trial to assess the efficacy and safety of idelalisib
-
1:10
fda approves argenx's vyvgart to treat myasthenia gravis
-
32:15
research webinar: update on rozanolixizumab
-
4:54
generalized myasthenia gravis